$TirzepatidePriceGuide
Safety & eligibility

Tirzepatide safety & eligibility

Tirzepatide is prescription-only. Here's a plain-English overview of side effects, contraindications, and who decides whether it's appropriate for you. This is education, not medical advice.

Released: · Last reviewed:

Researched By
Dr. Parmis
Medical Researcher · Western University of Health Sciences
Medically Reviewed By
Dr. Jonathan Snipes, MD · Kim Callender, NP (FNP-BC)
Last medically reviewed: July 8, 2026 · This page is informational and does not constitute medical advice.

Common side effects

The most common side effects are gastrointestinal — nausea, vomiting, diarrhea, constipation, and abdominal discomfort — usually mild-to-moderate and most pronounced during dose escalation. Slower titration and dietary adjustments can help; talk to your prescriber about persistent symptoms.

Serious risks & contraindications

Tirzepatide carries a boxed warning regarding thyroid C-cell tumors observed in rodents. It is contraindicated in people with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Other considerations include pancreatitis, gallbladder disease, severe gastrointestinal disease, and pregnancy/breastfeeding. Disclose your full history to your prescriber.

Who decides eligibility

Only a licensed clinician can determine whether tirzepatide is appropriate for you, and eligibility is never guaranteed. Compounded tirzepatide is not FDA-approved; brand-name Zepbound (weight) and Mounjaro (type 2 diabetes) are FDA-approved.

If you experience severe abdominal pain, signs of an allergic reaction, or persistent vomiting, seek medical care. This page does not replace professional medical advice.

See the SURMOUNT-1 summary and full references.

Keep reading

Explore the price guide